Changing paradigms in organ preservation and resuscitation

Current Opinion in Organ Transplantation

Volumn 20, Issue 2, 2015, Pages 152-158

  Ali, Fadwa ^a   Dua, Anahita ^a   Cronin, David C ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

ex vivo machine perfusion; organ preservation solution; organ transplantation

Indexed keywords

PRESERVATION SOLUTION; PROTECTIVE AGENT;

ALLOGRAFT; GRAFT PERFUSION; HEART; HEART TRANSPLANTATION; HUMAN; KIDNEY; KIDNEY DONOR; KIDNEY GRAFT; LIVER; LIVER GRAFT; LIVER TRANSPLANTATION; LUNG; LUNG ALLOGRAFT; LUNG TRANSPLANTATION; MACHINE; MEDICAL DEVICE; MEDICAL RESEARCH; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; PANCREAS; PANCREAS TRANSPLANTATION; PERFUSION DEVICE; RESUSCITATION; REVIEW; SURVIVAL; ANIMAL; DEVICES; DONOR; PERFUSION; PROCEDURES; SUPPLY AND DISTRIBUTION;

ANIMALS; HUMANS; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PERFUSION; RESUSCITATION; TISSUE DONORS;

EID: 84938850807     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000180     Document Type: Review

References (44)

1. Vogel T, Brockmann JG, Friend PJ. Ex-vivo normo thermic liver perfusion. Curr Opin Organ Transplant 2010; 15:167-172.
2. Van Raemdonck D, Neyrinck A, Rega F, et al. Machine perfusion in organ transplantation: a tool for ex-vivo graft conditioning with mesenchymal stem cells? Curr Opin Organ Transplant 2013; 18:24-33.
3. Balfoussia D, Yerrakalva D, Hamaoui K, Papalois V. Advances in machine perfusion graft viability assessment in kidney, liver, pancreas, lung, and heart transplant. Exp Clin Transplant 2012; 10:87-100.
4. Organ Procurement and Transplantation Network (OPTN). A Guide to Calculating and Interpreting the Kidney Donor Profile Index (KDPI). 2014. http://optn.transplant.hrsa.gov/ContentDocuments/Guide-to-Calculating- Interpreting-KDPI.pdf. Accessed 16 February 2015.
5. Gallinat A, Moers C, Smits JM, et al. Machine perfusion versus static cold storage in expanded criteria donor kidney transplantation: 3-year follow-up data. Transpl Int 2013; 26:E52-E53.
6. Brook NR, Waller JR, Nicholson ML. Non heart-beating kidney donation: current practice and future developments. Kidney Int 2003; 63:1516-1529.
7. Jochmans I, Moers C, Ploeg R, Pirenne J. To perfuse or not to perfuse kidneys donated after cardiac death. Am J Transplant 2011; 11:409-410.
8. Monbaliu D, Brassil J. Machine perfusion of the liver: past, present and future. Curr Opin Organ Transplant 2010; 15:160-166.
9. Op den Dries S, Karimian N, Sutton ME, et al. Ex vivo normothermic machine perfusion and viability testing of discarded human donor livers. Am J Transplant 2013; 13:1327-1335.
10. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant 2010; 10:372-381.
11. Sutton ME, Op den Dries S, Karimian N, et al. Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion. PLoS One 2014; 9:e110642.
12. Goto M, Kawano S, Yoshihara H, et al. Hepatic tissue oxygenation as a predictive indicator of ischemia-reperfusion liver injury. Hepatology 1992; 15:432-437.
13. Kamiike W, Nakahara M, Nakao K, et al. Correlation between cellular ATP level and bile excretion in the rat liver. Transplantation 1985; 39:50-55.
14. Hong JC, Koroleff D, Xia V, et al. Regulated hepatic reperfusion mitigates ischemia and reperfusion injury and improves survival after prolonged liver warm ischemia: a pilot study on a novel concept of organ resuscitation in a large animal model. J Am Coll Surg 2012; 214:505-515.
15. Leeser DB, Bingaman AW, Poliakova L, et al. Pulsatile pump perfusion of pancreata before human islet cell isolation. Transplant Proc 2004; 36:1050-1051.
16. Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364:1431-1440.
17. Andreasson AS, Dark JH, Fisher AJ. Ex vivo lung perfusion in clinical lung transplantation-state of the art. Eur J Cardiothoracic Surg 2014; 46:779-788.
18. Ciubotaru A, Haverich A. Ex vivo approach to treat failing organs: expanding the limits. Eur Surg Res 2015; 54:64-74.
19. Steen S, Sjöberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet 2001; 357:825-829.
20. Ingemansson R, Eyjolfsson A, Mared L, et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 2009; 87:255-260.
21. Mohite P, Sabashnikov A, Garcia Saez D, et al. Utilization of the Organ Care System Lung for the assessment of lungs form a donor after cardiac death (DCD) before bilateral transplantation. Perfusion 2014; 29:1-4.
22. U.S. Food and Drug Administration. FDA approves donor lung preservation device that may result in more lung transplants. 2014. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm409488.htm. Accessed 16 February 2015.
23. Rosenbaum DH, Peltz M, DiMaio JM, et al. Perfusion preservation versus static preservation for cardiac transplantation: effects on myocardial function and metabolism. J Heart Lung Transplant 2008; 27:93-99.
24. ClinicalTrials.gov. Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation (PROCEEDII). First received March 3, 2009; last updated July 29, 2013. https://www. clinicaltrials.gov/ct2/show/NCT00855712?term=TransMedics&rank=2. Accessed 16 February 2015.
25. Koerner MM, Ghodsizad A, Schulz U, et al. Normothermicexvivo allograft blood perfusion in clinical heart transplantation. Heart Surg Forum 2014; 17:E141-E145. This study describes the first human clinical use of the OCS heart for ex-vivo resuscitation and subsequent transplantation.
26. TM) Heart Technology was Used to Perform the World's First Series of Adult Human Heart Transplants from Donors after Circulatory Death (DCD Donors) at St Vincent's Hospital in Sydney, Australia. 2014. Andover, Massachusetts, USA; 24 October 2014. http://www.transmedics.com/wt/page/pr-1414117691. Accessed 16 February 2015.
27. Ghodsizad A, Bordel V, Ungerer M, et al. Ex vivo coronary angiography of a donor heart in the organ care system. Heart Surg Forum 2012; 15:E161-E163.
28. Parsons RF, Guarrera JV. Preservation solutions for static cold storage of abdominal allografts: which is best? Curr Opin Organ Transplant 2014; 19:100-107.
29. Latchana N, Peck JR, Whitson B, Black SM. Preservation solutions for cardiac and pulmonary donor grafts: a review of the current literature. J Thorac Dis 2014; 6:1143-1149.
30. O'Callaghan JM, Knight SR, Morgan RD, Morris PJ. Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis. Am J Transplant 2012; 12:896-906.
31. O'Callaghan JM, Morgan RD, Knight SR, Morris PJ. The effect of preservation solutions for storage of liver allografts on transplant outcomes: a systematic review and meta-analysis. Ann Surg 2014; 260:46-55.
32. Zuluaga GLL, Agudelo RES, Tobon JJZ. Preservation solutions for liver transplantation in adults: Celsior versus Custodiol: a systematic review and meta-analysis with an indirect comparison of randomized trials. Transplant Proc 2013; 45:25-32.
33. Schneeberger S, Biebl M, Steurer W, et al. A prospective randomized multicenter trial comparing histidine tryptophane-ketoglutarate versus University of Wisconsin perfusion solution in clinical pancreas transplantation. Transpl Int 2009; 22:217-224.
34. Alonso D, Dunn TB, Rigley T, et al. Increased pancreatitis in allografts flushed with histidine-tryptophan-ketoglutarate solution: a cautionary tale. Am J Transplant 2008; 8:1942-1945.
35. Stewart ZA, Cameron AM, Singer AL, et al. Histidine-tryptophan-ketoglu-tarate (HTK) is associated with reduced graft survival in pancreas transplantation. Am J Transplant 2009; 9:217-221.
36. Cursio R. Caspase inhibition in liver transplantation: from basic science to clinical studies. HPB (Oxford) 2010; 12:1-3.
37. Zhai Y, Petrowsky H, Hong JC, et al. Ischaemia-reperfusioninjury in liver transplantation-from bench to bedside. Nat Rev Gastroenterol Hepatol 2013; 10:79-89.
38. Hammerman MR. Renal tissue engineering and regeneration. In: In: Brenner BM, editor. Brenner & Rector's the kidney, 8th ed. San Diego: Elsevier; 2007. pp. 2199-2214. (Chapter 68).
39. Hammerman MR. Underpinnings of cellular organ replacement therapies. Curr Opin Organ Transplant 2014; 19:131-132.
40. Fukui A, Yokoo T. Kidney regeneration using developing xenoembryo. Curr Opin Organ Transplant 2015; 20:160-164.
41. Kim I-H, Ko IK, Atala A, Yoo JJ. Whole kidney engineering for clinical translation. Curr Opin Organ Transplant 2015; 20:165-170.
42. Mae S-I, Osafune K. Kidney regeneration from human induced pluripotent stem cells. Curr Opin Organ Transplant 2015; 20:171-177.
43. Little MH, Takasato M. Generating a self-organising kidney from pluripotent cells. Curr Opin Organ Transplant 2015; 20:178-186.
44. Lam AQ, Bonventre JV. Regenerating the nephron with human pluripotent stem cells. Curr Opin Organ Transplant 2015; 20:187-192.